Aster Capital Management (Difc) LTD Immunome Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Immunome Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 327 shares of IMNM stock, worth $3,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
327Holding current value
$3,400% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
125Shares Held
45.7MCall Options Held
74KPut Options Held
2.04M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.5MShares$57.2 Million0.04% of portfolio
-
Redmile Group, LLC San Francisco, CA4.83MShares$50.2 Million3.87% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$40.3 Million1.86% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$39.1 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.46MShares$35.9 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $126M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...